SEC Form 4 · accession 0000899243-17-021480
Global Blood Therapeutics, Inc. · GBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Radovich
Officer — See Remarks
Period of report
Aug 31, 2017
Accepted (ET)
Sep 5, 2017 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001629137
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2017 | S | 2,410 | $30.00 | D | 2,684 | D | |
| Common Stock | holding | — | — | — | 12,500 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Remarks
Senior Vice President, Operations